Current and future medical treatments for endometriosis
article
OA: closed
CC0
AI-generated summary
Current medical treatments for endometriosis, including hormonal therapies, aim to suppress lesion growth, while future strategies explore anti-inflammatory and antiangiogenesis compounds for a multi-pronged approach.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a chronic condition characterized by dysmenorrhea, dyspareunia, pelvic pain, and infertility. Endometriosis is often treated surgically upon diagnosis, but a high rate of recurrence suggests that a combination of surgical and medical management might provide better outcomes. The primary goal of medical treatment is to interrupt the growth and activity of endometriotic lesions. Due to the chronic nature of this disease, long-term or repeated courses of medication may be required to control symptoms. Medical treatments now recognize the use of gonadotropin-releasing hormone agonists, oral contraceptives, danazol, and progestins. Increasing knowledge about the pathogenesis of endometriosis is providing the opportunity to use new agents for treatment, including anti-inflammatory and antiangiogenesis compounds, to prevent or inhibit the development of endometriosis. The future outlook is to use a multiple approach for treating women with endometriosis with the goal of eradicating the disease and eliminating the symptoms.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-11T07:50:29.529165+00:00
License: CC0
· commercial use OK